Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Verastem, Inc. (VSTM) Institutional Ownership & Insider Trading

158 institutions reported holding Verastem, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 34 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VSTMVerastem, Inc.Follow VSTM — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
909.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

158 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +21.5%.

Increased+67New+30Decreased-35Closed-21

Largest moves, shares (millions)

Nantahala Capital Management+3.6MBlackRock+3.0MVanguard Portfolio…+2.5MCitadel Advisors-2.0MMorgan Stanley-1.5MJ. Goldman-1.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+10.9Sep 24+7.2Dec 24+8.6Mar 25+9.3Jun 25+6.7Sep 25+12.6Dec 25+4.8Mar 26+17.5Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2615899+21.5%67303521
Mar 2615581+6.7%68331923
Dec 2514277+21.6%48363018
Sep 2511560+12.6%37233618
Jun 2510853+21.4%43262115
Mar 259843+25.5%34192211
Dec 249034+27.0%34241012
Sep 247427+80.5%341779

Verastem, Inc. — questions

Who owns Verastem, Inc. stock?
158 institutions reported Verastem, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.2%), Nantahala Capital Management, LLC (7.9%), ARMISTICE CAPITAL, LLC (7.8%).
Are Verastem, Inc. insiders buying or selling?
34 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Verastem, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.